Search by Drug Name or NDC

    NDC 61919-0901-30 CYCLOBENZAPRINE HCL 5 mg/1 Details

    CYCLOBENZAPRINE HCL 5 mg/1

    CYCLOBENZAPRINE HCL is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by DIRECTRX. The primary component is CYCLOBENZAPRINE HYDROCHLORIDE.

    Product Information

    NDC 61919-0901
    Product ID 61919-901_fd766c38-e406-49e5-e053-6294a90aaf36
    Associated GPIs 75100050100303
    GCN Sequence Number 047478
    GCN Sequence Number Description cyclobenzaprine HCl TABLET 5 MG ORAL
    HIC3 H6H
    HIC3 Description SKELETAL MUSCLE RELAXANTS
    GCN 12805
    HICL Sequence Number 001950
    HICL Sequence Number Description CYCLOBENZAPRINE HCL
    Brand/Generic Generic
    Proprietary Name CYCLOBENZAPRINE HCL
    Proprietary Name Suffix n/a
    Non-Proprietary Name CYCLOBENZAPRINE HCL
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name CYCLOBENZAPRINE HYDROCHLORIDE
    Labeler Name DIRECTRX
    Pharmaceutical Class Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077797
    Listing Certified Through 2024-12-31

    Package

    NDC 61919-0901-30 (61919090130)

    NDC Package Code 61919-901-30
    Billing NDC 61919090130
    Package 30 TABLET, FILM COATED in 1 BOTTLE (61919-901-30)
    Marketing Start Date 2019-04-04
    NDC Exclude Flag N
    Pricing Information N/A